NCT07311967

Brief Summary

This study examines the short-term respiratory and cognitive effects of exposure to ultrafine particles (UFPs) generated during typical household cooking. Healthy adults will complete two 6-hour sessions in a controlled exposure chamber at the University of Illinois Chicago: one control day with clean indoor air and one exposure day during which standardized cooking (frying potatoes and grilling beef) is performed by research staff. Participants will not cook or handle food. Lung function will be measured using peak expiratory flow (PEF), and cognitive performance will be assessed using validated tests including the Hopkins Verbal Learning Test-Revised and the Processing Speed Index from the WAIS-IV. Airborne particle and gas concentrations in the chamber will be continuously monitored to ensure that exposures remain within levels typical of everyday home cooking. Findings will help characterize acute physiological responses to indoor cooking emissions and inform future research on indoor air quality and potential mitigation strategies.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Jan 2026Jun 2026

First Submitted

Initial submission to the registry

November 28, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 31, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

January 2, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

December 31, 2025

Status Verified

December 1, 2025

Enrollment Period

2 months

First QC Date

November 28, 2025

Last Update Submit

December 16, 2025

Conditions

Keywords

Cooking emissionsNeurocognitive functionRespiratory symptomsUltrafine particles

Outcome Measures

Primary Outcomes (3)

  • Change in Hopkins Verbal Learning Test-Revised (HVLT-R) Total Recall Score

    Cognitive performance related to verbal memory will be assessed using the Hopkins Verbal Learning Test-Revised (HVLT-R). The primary metric will be the change in HVLT-R Total Recall Score between exposure and control conditions, calculated from repeated assessments to evaluate short-term cognitive effects of ultrafine particle exposure.

    Measured at baseline and at approximately 1, 2, 3, and 5 hours after session start on both study days

  • Change in Peak Expiratory Flow (PEF)

    Peak Expiratory Flow (PEF) will be measured using a handheld peak flow meter to assess short-term changes in lung function following exposure to cooking-generated ultrafine particles compared with the clean-air control day. Changes are evaluated within subjects using repeated measurements across both conditions.

    Measured at baseline and at approximately 1, 2, 3, and 5 hours after session start on both study days

  • Change in WAIS Symbol Search Raw Score

    Cognitive performance related to processing speed and visual attention will be assessed using the Symbol Search subtest of the Wechsler Adult Intelligence Scale (WAIS). The primary metric will be the change in WAIS Symbol Search raw score between exposure and control conditions, calculated from repeated assessments to evaluate short-term cognitive effects of ultrafine particle exposure.

    Measured at baseline and at approximately 1, 2, 3, and 5 hours after session start on both study days

Secondary Outcomes (6)

  • Ultrafine Particle Number Size Distribution in particles/cm3

    Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods.

  • Fine Particle Mass Concentrations (PM2.5) in microgram/cm3

    Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods

  • Total Volatile Organic Compound (VOC) concentration in ppm

    Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods

  • CO2 concentration in ppm

    Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods

  • CO concentration in ppm

    Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods

  • +1 more secondary outcomes

Other Outcomes (3)

  • Temperature Condition in Exposure Chamber

    Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods

  • Number of Participants Reporting Acute Symptoms During Study Sessions

    Assessed at baseline and at approximately 1, 2, 3, and 5 hours after session start on control and exposure days

  • Relative Humidity Condition in Exposure Chamber

    Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods

Study Arms (2)

Control Condition (Clean Indoor Air)

OTHER

Participants will complete a control study session conducted in a controlled exposure chamber with clean indoor air and no cooking activity. Respiratory, cognitive, and physiological outcomes will be assessed during the session.

Other: Clean Indoor Air Exposure (Control)

Cooking Emissions Exposure

EXPERIMENTAL

Participants will complete an exposure study session conducted in the same controlled exposure chamber during which cooking activities generate ultrafine particles. Respiratory, cognitive, and physiological outcomes will be assessed during the session.

Other: Exposure to Cooking-Generated Ultrafine Particles and Gases

Interventions

Participants will be exposed to clean indoor air in a controlled exposure chamber with no cooking activity. This condition serves as the control session for within-subject comparisons.

Control Condition (Clean Indoor Air)

Participants will be exposed to cooking-generated ultrafine particles and associated gases in a controlled exposure chamber during standardized cooking activities.

Cooking Emissions Exposure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults 18 years of age or older
  • Able to understand and speak English sufficiently to complete cognitive testing
  • Able and willing to complete two consecutive study sessions lasting approximately 6 hours each
  • Able to avoid cooking, toasting, and fume-generating household activities (e.g., strong cleaning products, ironing, hair drying) for 24 hours before each session
  • Able to avoid tobacco, marijuana, vaping, and alcohol use as specified in the study protocol
  • Able to provide informed consent

You may not qualify if:

  • Younger than 18 years old
  • Pregnant or planning pregnancy during study participation
  • Current smoking or use of:
  • Cigarettes
  • E-cigarettes or vaping devices
  • Marijuana
  • Shisha/hookah
  • Binge drinking, heavy alcohol use, or inability to abstain from alcohol for 24 hours before study visits
  • Restaurant chefs or individuals who perform frequent commercial-level cooking
  • Individuals who cook two or more frying or grilling meals per day at home
  • Cooking anxiety or mageirocophobia
  • Any diagnosed neurological disease, including stroke, seizure disorder, multiple sclerosis, traumatic brain injury, dementia, or similar conditions
  • Any significant respiratory disease, including:
  • Chronic obstructive pulmonary disease (COPD)
  • Untreated severe asthma
  • +9 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UIC

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Conditions

Signs and Symptoms, Respiratory

Interventions

Gases

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Inorganic Chemicals

Study Officials

  • Mehdi Amouei Torkmahalleh, PhD

    University of Illinois Chicago

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mehdi Amouei Torkmahalleh, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: This study uses a two-period randomized crossover design in which each participant completes both conditions: a control session with clean indoor air and an exposure session involving cooking-generated ultrafine particles. The two sessions occur on consecutive days in the same controlled exposure chamber, and participants serve as their own control to allow within-subject comparisons of respiratory and cognitive responses.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 28, 2025

First Posted

December 31, 2025

Study Start

January 2, 2026

Primary Completion

March 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

December 31, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because this study does not collect biospecimens and all data are used solely for the analyses specified in the protocol. Data are stored in coded form and are not intended for secondary research use. In addition, screening data for ineligible individuals are destroyed within 3 days, and no identifiable information is retained beyond what is required for regulatory documentation. Only aggregate, de-identified results may be shared with participants upon request, but individual-level datasets will not be made available to external researchers.

Available IPD Datasets

Study Protocol Access
Informed Consent Form Access
Recruitment Email Access
Screening Materials Access

Locations